Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
05/23/1995 | US5418251 Topical composition for accelerating wound healing |
05/23/1995 | CA1335672C Thioformamide derivatives |
05/23/1995 | CA1335624C Synthetic aluminum silicate preparation |
05/18/1995 | WO1995013064A1 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists |
05/18/1995 | WO1995013062A1 Butyric ester cyto-differentiating agents |
05/18/1995 | WO1995013048A1 Desquamation compositions containing salicylic acid and zwitterionic compounds |
05/18/1995 | CA2176124A1 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists |
05/18/1995 | CA2175249A1 Butyric ester cyto-differentiating agents |
05/17/1995 | EP0653214A1 Topical antibacterial preparation |
05/17/1995 | EP0652872A1 Optically pure salts of pyridinylmethyl sulfinyl-1h-benzimidazole compounds |
05/17/1995 | EP0652760A1 Therapeutic methods using caesium ions |
05/17/1995 | EP0652749A1 METHODS AND COMPOSITIONS FOR INHIBITING 5$g(a)-REDUCTASE ACTIVITY |
05/17/1995 | CN1102643A Substituted derivatives of diaminophthalimide |
05/17/1995 | CN1102583A Application of Chinese herb Job's tears seed extract |
05/16/1995 | US5416194 Extracted from horseshoe crab |
05/16/1995 | US5416113 Bronchodilators |
05/16/1995 | CA1335588C Antimicrobial superabsorbent compositions and methods |
05/16/1995 | CA1335568C Cosmetic and skin treatment compositions |
05/12/1995 | CA2135139A1 Topical antibacterial preparation |
05/11/1995 | WO1995012581A1 Pseudodipeptide product having an imidazole grouping and applications |
05/11/1995 | WO1995012397A1 Plaster for treating nail mycoses |
05/11/1995 | WO1995012393A1 Plaster for the treatment of nail mycoses |
05/11/1995 | WO1995012389A1 Multilamellar liposomal arachidonic acid metabolite formulations |
05/11/1995 | WO1995012388A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations |
05/11/1995 | CA2175896A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations |
05/11/1995 | CA2175057A1 Multilamellar liposomal arachidonic acid metabolite formulations |
05/10/1995 | EP0652010A1 Use of alphatocopherol acetate or a derivative for the preparation of cosmetic, dermatalogical or pharmaceutical compositions with anti radical activity |
05/10/1995 | EP0651992A1 Use of soaps as antiageing agents in cosmetic and/or dermatological compositions |
05/10/1995 | EP0651641A1 Novel bioactive compositions, preparation and use thereof |
05/10/1995 | EP0651637A1 Control of wound scar production with calcium antagonists alone or in a combination with a steroid |
05/10/1995 | CN1102340A Medicine for acne |
05/09/1995 | US5413791 Collagen-polymer conjugates |
05/09/1995 | CA1335501C Methods for preparing sucralfate and aa1-10001 |
05/06/1995 | CA2135131A1 Use of soaps as anti-agers in cosmetic or dermatologic compositions |
05/04/1995 | WO1995011883A1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation |
05/04/1995 | WO1995011881A1 Phytosphingosine-based ceramide i analogs |
05/04/1995 | WO1995011687A1 Therapeutic use of cis-element decoys in vivo |
05/04/1995 | WO1995011676A1 Long-acting antifungal o/w preparation |
05/04/1995 | CA2170736A1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation |
05/04/1995 | CA2134950A1 Method and compositions for stimulating intracellular glutathione |
05/03/1995 | EP0650725A1 Compositions containing salts of L-2-oxothiazolidine-4-carboxylic acid and their use for stimulating intracellular glutathione |
05/03/1995 | EP0650366A1 Compositions and methods for treating wounds |
05/02/1995 | US5411991 Applying to human skin, beards, reaction with cysteine |
05/02/1995 | US5411978 Benzisothiazolinone-1-dioxide derivatives as elastase inhibitors |
05/02/1995 | US5411949 23-oxa-derivatives in the vitamin D series, process for their production, pharmaceutical preparations containing these derivatives as well as their use pharmaceutical agents |
05/02/1995 | US5411728 Sunscreen agents |
05/02/1995 | CA1335452C Substituted tetralins, chromans and related compounds in the treatment of asthma |
04/27/1995 | WO1995011309A2 A novel nuclear mitotic phosphoprotein: mitosin |
04/27/1995 | WO1995011259A1 Platelet-derived growth factor analogues |
04/27/1995 | WO1995011257A1 Ks-laminin and methods of use |
04/27/1995 | WO1995011254A1 16-substituted-4-aza-androstane 5-alpha-reductase isozyme 1 inhibitors |
04/27/1995 | WO1995011017A1 Ibuprofen and flurbiprofen as anti-pruritic agents |
04/27/1995 | WO1995011015A1 Composition and method for treating blood vessel disorders of the skin using vitamin k |
04/27/1995 | WO1994027594A3 Stable copper(i) complexes and methods related thereto |
04/27/1995 | CA2174666A1 Composition and method for treating blood vessel disorders of the skin using vitamin k |
04/27/1995 | CA2174619A1 Ibuprofen and flurbiprofen as anti-pruritic agents |
04/27/1995 | CA2173978A1 A novel nuclear mitotic phosphoprotein: mitosin |
04/27/1995 | CA2173363A1 Ks-laminin and methods of use |
04/26/1995 | EP0649412A1 Pharmaceutical pyridine compounds |
04/26/1995 | EP0649409A1 Vinyl arenas having retinoid-like activity |
04/26/1995 | EP0649405A1 22-ene-25-oxa derivatives of the vitamin d series, method of preparing such derivatives, pharmaceutical preparations containing them and thus use of such preparations as drugs. |
04/26/1995 | EP0649274A1 Aqueous compositions comprising an organic peroxiacid |
04/26/1995 | EP0539465B1 Use of 20(r)-22-oxa-vitamin d analogues in the manufacture of a medicament for the treatment of skin ageing |
04/26/1995 | CN1101915A New 19-nor steroids having a phenoxyalkylsulphonamide or phenoxyalkylsulphonylurea chain in position llbeta, preparation process and intermediates, use as medicaments and pharmaceutical compositions.. |
04/25/1995 | US5410061 Pharmaceutical compounds |
04/25/1995 | CA2020877C Stable tretinoin emulsified cream formulations |
04/20/1995 | WO1995010539A1 Growth differentiation factor-10 |
04/20/1995 | WO1995010305A1 Inhibition of extracellular matrix synthesis by antisense compounds directed to nuclear proto-oncogenes |
04/20/1995 | WO1995010284A1 Method of treating androgenic alopecia with 5-alpha reductase inhibitors |
04/20/1995 | WO1995010271A2 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
04/20/1995 | CA2171546A1 Growth differentiation factor-10 |
04/19/1995 | EP0648496A1 Therapeutic compositions for use in the treatment of skin lesions and method of making same |
04/19/1995 | EP0648488A1 Method to alter hairgrowth and compositions therefor |
04/19/1995 | EP0648209A1 Contrast agents for mr diagnosis |
04/19/1995 | EP0648208A1 Indole derivatives as testosterone 5 alpha-reductase inhibitors |
04/19/1995 | EP0580803A4 Antimicrobial compositions useful for medical applications. |
04/19/1995 | CN1028227C Pharmacologically active 1,5-diarly-3-substituted-pyrazoles and method for synthesizing the same |
04/18/1995 | US5407939 Fluorinated 17 β-substituted 4-aza-5 α-androstan-3-one derivatives |
04/18/1995 | US5407915 Human Bikunin variants as proteinase inhibitors, and medicaments containing these |
04/18/1995 | US5407671 Mixture of fibrinogen, blood coagulation factor xiii, prothrombin, antitrombin, calcium compound and aprotinin |
04/18/1995 | CA2022917C Synergistic skin depigmentation composition |
04/18/1995 | CA1335284C Pharmaceutical product having epidermal regenerative activity based on the active ingredient of mimosa tenuiflora and process for its obtention |
04/16/1995 | CA2118200A1 Therapeutic compositions for use in the treatment of skin lesions and method of making same |
04/13/1995 | WO1995009921A1 Platelet-activating factor acetylhydrolase |
04/13/1995 | WO1995009862A1 Water-soluble retinoids |
04/13/1995 | WO1995009857A1 O-aryl, o-alkyl, o-alkenyl and o-alkynyl-macrolides having immunosuppressive activity |
04/13/1995 | WO1995009853A1 Pharmacologically active pyridine derivatives and processes for the preparation thereof |
04/13/1995 | WO1995009626A1 Mycophenolate mofetil high dose oral suspensions |
04/13/1995 | WO1995009590A1 Absorption enhancers for topical pharmaceutical formulations |
04/13/1995 | WO1995000501A3 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
04/13/1995 | CA2172124A1 O-aryl, o-alkyl, o-alkenyl and o-alkynyl-macrolides having immunosuppressive activity |
04/12/1995 | EP0647617A1 Ceramides, process for their preparation and their cosmetic uses |
04/12/1995 | EP0647219A1 Derivatives in the vitamin d series modified at the 20 position, a method of preparing such derivatives, intermediates used in this method, pharmaceutical preparations containing the derivatives and their use in the preparation of drugs. |
04/12/1995 | EP0428668B1 Water-soluble vitamin a preparations for application to the skin |
04/12/1995 | CN1028174C Process and intermediates for preparing compounds having disubstituted acetylene moiety and retinoic acid-like biological activity |
04/11/1995 | US5406014 Dehydrogenation processes, equipment and catalyst loads therefor |
04/11/1995 | US5405838 Topical powder compositions containing a cyclic AMP derivative |
04/06/1995 | WO1995009007A1 Monoglyceride/lactate ester permeation enhancer for oxybutynin |
04/06/1995 | WO1995009006A1 Monoglyceride/lactate ester permeation enhancer |
04/06/1995 | WO1995008985A1 Perfluorocarbons as anti-inflammatory agents |